News & Events


Events

See the BD Calendar of Events



News

5 November, 2012
New, Fully Automated Diagenode Respiratory FLU A/B Assay Validated for Use on the BD MAX™ System

18 October, 2012
New Molecular Test Available to Diagnose Trichomonas vaginalis in Asymptomatic and Symptomatic Females

15 October, 2012
BD and Lab21 Collaborate to Develop New Oncology Assays on the BD MAX™ Platform

24 November, 2011
First Healthcare-Associated Infection Assay on the BD MAX™ System Launches in Europe.

18 August, 2011
BD Diagnostics and Biodiversity Collaborate to Develop Portfolio of Assays on the BD MAX™ System

3 August, 2011
BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System

10 June, 2011
Experience EpiCenter™ Workshop, 29th June. Presentation

3 May, 2011
First fully automated, FDA-cleared molecular assays for HSV1 and HSV2

11 April, 2011
New Amplified Molecular Tests Launched to Help Improve Diagnosis and Treatment of Herpes Patients

11 April, 2011
E-Learning Centre

21 March, 2011
World TB Day Donation Campaign Increases Access to Improved TB Tests in Resource-Limited Settings

9 March, 2011
BD Launches Unique System for Safe Transportation of Blood Culture Vials

13 December, 2010
Swift and simple diagnosis of Influenza

21 October, 2010
BACTEC™ User Group (BUG) 2010 Presentations

4 October, 2010
BD Diagnostics and Bruker Collaborate to Improve Microbial Identification and Antimicrobial Susceptibility Testing

11 August, 2010
The BD Innova™ Advanced Specimen Processor - Experience Efficiency

15 July, 2010
Introducing the BD MAX™ - Fully Automated Bench-top System for Molecular Diagnostics

15 June, 2010
BD Announces European Launch of the BD MAX™ System for Molecular Diagnostics

20 April, 2010
Updated BD BBL™ Crystal™ MIND Software Available for FREE Download

8 April, 2010
BD Expands Diagnostics Portfolio with Advanced Automated Microbiology Specimen Processor

7 April, 2010
ECCMID 2010 - Come and visit us at the BD booth no. 561

15 January, 2010
BD Group B Streptococcus Differential Agar (Granada Medium)

14 January, 2010
BD launches education course for laboratory professionals.

7 January, 2010
Help women prevent Cervical Cancer

20 November, 2009
BD Completes Acquisition of HandyLab, Inc.

30 October, 2009
Reliable detection, identification and screening with BD BBL™ CHROMagar™ Products.»

30 October, 2009
Maximizing Productivity with BD Phoenix™ AP »

30 October, 2009
Make the BD FocalPoint™ GS Imaging System your guide in cervical cytology screening.

30 October, 2009
Launch of BD MGIT™ TBc Identification Test in Africa and the European Union »

23 October, 2009
BD Announces Agreement to Acquire HandyLab, Inc.

7 October, 2009
HAI - Literature References

28 September, 2009
BD Receives Health Canada Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer

12 August, 2009
BD BACTEC™ FX Next Generation Blood Culture System

6 August, 2009
BD Adds Surveillance Capability to Infectious Disease Portfolio »

18 May, 2009
BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays »

4 May, 2009
BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management

26 February, 2009
New BD BACTEC™ FX Blood Culture System with the BD EpiCenter™ Microbiology Data Management System now Available Worldwide

7 July, 2008
BD GeneOhm™ Cdiff Assay CE Marked and Submitted for FDA Clearance

2 June, 2008
New BD BACTEC™ FX Blood Culture Instrument with the BD EpiCenter™ Operating System can Facilitate Fast and Effective Clinical Decisions for Patients with Bacterial Infections

17 March, 2008
BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates

 

Unless otherwise noted, BD, BD logo and all other trademarks are property of Becton Dickinson and Company. © 2013 BD